U.S. Physical Therapy (NYSE:USPH) Earns "Market Outperform" Rating from JMP Securities

JMP Securities reissued their market outperform rating on shares of U.S. Physical Therapy (NYSE:USPH - Free Report) in a report issued on Tuesday,Benzinga reports. JMP Securities currently has a $113.00 price target on the stock.

Other equities analysts also recently issued research reports about the stock. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. StockNews.com lowered U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research report on Thursday, April 17th. Barrington Research lowered their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. Finally, JPMorgan Chase & Co. reduced their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Wednesday, March 19th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $109.00.

U.S. Physical Therapy Price Performance

NYSE:USPH traded up $1.10 on Tuesday, hitting $70.78. The company had a trading volume of 81,078 shares, compared to its average volume of 107,158. The firm has a 50 day moving average of $74.63 and a two-hundred day moving average of $84.38. The stock has a market capitalization of $1.08 billion, a price-to-earnings ratio of 75.30, a PEG ratio of 3.54 and a beta of 1.38. U.S. Physical Therapy has a 52 week low of $62.77 and a 52 week high of $108.14. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). The firm had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, research analysts anticipate that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 14th were given a dividend of $0.45 per share. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.80 annualized dividend and a dividend yield of 2.54%. U.S. Physical Therapy's payout ratio is presently 97.83%.

Insider Buying and Selling

In other news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This trade represents a 19.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

Several institutional investors have recently added to or reduced their stakes in the business. CBIZ Investment Advisory Services LLC boosted its holdings in U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after buying an additional 122 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter worth about $39,000. Venturi Wealth Management LLC boosted its holdings in U.S. Physical Therapy by 3,200.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after purchasing an additional 704 shares during the period. Lazard Asset Management LLC bought a new stake in U.S. Physical Therapy during the fourth quarter valued at $84,000. Finally, Fifth Third Bancorp raised its holdings in shares of U.S. Physical Therapy by 34.6% in the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock valued at $75,000 after acquiring an additional 265 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.